Virtual West Oncology Conference
Playback speed
10 seconds
2021 Advanced NSCLC Targeted Therapy Updates: Efficacy & Safety Profile of Larotrectinib & Entrectinib for NTRK Fusion, Dabrafenib+Trametinib Combo in BRAF Mutated Disease
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
151 views
March 4, 2021
Comments 0
Login to view comments.
Click here to Login
Videos